Indaptus Therapeutics, Inc.
Recent Filings
All 303 filings →| Form | Description | Date |
|---|---|---|
| 8-K | 8-K | Mar 24, 2026 |
| SCHEDULE 13D/A | — | Mar 24, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 24, 2026 |
| 10-K | 10-K | Mar 17, 2026 |
| SCHEDULE 13D | — | Mar 2, 2026 |
| 4 | 4 | Feb 27, 2026 |
| 8-K | 8-K | Feb 27, 2026 |
| 3 | 3 | Feb 27, 2026 |
| 3 | FORM 3 | Feb 26, 2026 |
| 4 | 4 | Feb 13, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Sassi Nir | Chief Financial Officer | Award / Grant | 26,758 @ $2.03 | 26,758 | Dec 22, 2025 |
| Meckler Jeffrey A | Co-Chief Executive Officer | Award / Grant | 216,617 @ $2.03 | 229,929 | Dec 22, 2025 |
| Linscott Walt Addison | Chief Operating Officer | Award / Grant | 54,421 @ $2.03 | 54,426 | Dec 22, 2025 |
| Newman Michael James | CSO and Director | Award / Grant | 52,204 @ $2.03 | 101,074 | Dec 22, 2025 |
| Meckler Jeffrey A | Chief Executive Officer | Award / Grant | 6,068 @ $8.30 | 13,312 | Jul 27, 2025 |
| Meckler Jeffrey A | CEO and Director | Award / Grant | 42,553 @ $1.18 | 202,859 | Nov 25, 2024 |
| Meckler Jeffrey A | CEO and Director | Award / Grant | 84,932 @ $1.83 | 160,306 | Aug 8, 2024 |
| Anderson Glen R. | — | Purchase | 44,354 @ $1.94 | 1,131,402 | Aug 14, 2023 |
| Litchev Boyan Vesselinov | Chief Medical Officer | Purchase | 50 @ $4.09 | 150 | Nov 22, 2022 |
| Meckler Jeffrey A | CEO and Director | Purchase | 9,600 @ $1.90 | 75,374 | Nov 18, 2022 |